apl. Prof. Dr. Sebastian Jud

Department of Obstetrics and Gynaecology Medizinische Fakultät

Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center (2020) Löhberg C, Meyer J, Häberle L, Hack C, Jud S, Hein A, Wunderle M, et al. Journal article Association between breast cancer risk factors and molecular type in postmenopausal patients with hormone receptor-positive early breast cancer (2019) Wunderle M, Pretscher J, Brucker SY, Volz B, Hartmann A, Fießler C, Hein A, et al. Journal article Standard changing news der Senologie und der Gynäkologischen Onkologie 2019: Neue Arzneimittelzulassungen und Änderungen bestehender Therapiekonzepte (2019) Preuβ C, Hein A, Beckmann M, Jud S Journal article Prognostic effect of Ki-67 in common clinical subgroups of patients with HER2-negative, hormone receptor-positive early breast cancer (2019) Fasching P, Gaß P, Häberle L, Volz B, Hein A, Hack C, Lux MP, et al. Journal article Diagnostic Accuracy of Breast Medical Tactile Examiners (MTEs): A Prospective Pilot Study (2019) Lux MP, Emons J, Bani M, Wunderle M, Sell C, Preuss C, Rauh C, et al. Journal article A prediction model for pathological complete response after neoadjuvant chemotherapy of HER2-negative breast cancer patients (2018) Häberle L, Erber R, Gaß P, Hein A, Jud S, Langemann H, Rauh C, et al. Conference contribution Standard changing news der Senologie und der Gynäkologischen Onkologie 2018 (2018) Preu C, Heindl F, Jud S, Hein A, Hack C, Beckmann M, Lux MP, Rauh C Journal article Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients (2018) Hübner H, Fasching P, Gumbrecht W, Jud S, Rauh C, Matzas M, Paulicka P, et al. Journal article TILGen study-immunological targets in patients with breast cancer : Influence of tumor-infiltrating lymphocytes (2018) Erber R, Hartmann A, Beckmann M, Mackensen A, Kremer A, Reimann H, Hübner H, et al. Journal article Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients - a Survey Among Physicians (2018) Gaß P, Untch M, Mueller V, Moebus V, Thomssen C, Häberle L, Erber R, et al. Journal article